Ishikawa M, Nakatani H, Hori K: AtaA, a new member of the trimeri

Ishikawa M, Nakatani H, Hori K: AtaA, a new member of the trimeric autotransporter adhesins from Acinetobacter sp. Tol 5 mediating high

adhesiveness to various abiotic surfaces. PLoS One 2012, 7:e48830.PubMedCrossRef 29. Pósfai G, Koob M, Hradecná Z, Hasan N, Filutowicz M, Szybalski W: In vivo excision and amplification of large segments of the check details Escherichia coli genome. Nucleic Acids Res 1994, 22:2392–2398.PubMedCrossRef 30. Murphy KC: Use of bacteriophage lambda recombination functions to promote gene replacement in Escherichia coli . J Bacteriol 1998, 180:2063–2071.PubMed 31. Martínez-Gil M, Yousef-Coronado F, Espinosa-Urgel M: LapF, the second largest BYL719 Pseudomonas putida protein, contributes to plant root colonization and determines biofilm architecture. Mol Microbiol 2010, 77:549–561.PubMedCrossRef 32. Quandt J, Hynes MF: Versatile suicide vectors which allow direct selection for gene replacement in gram-negative bacteria. Gene 1993, 127:15–21.PubMedCrossRef 33. Schäfer A, Tauch A, Jäger W, Kalinowski J, Thierbach G, Pühler A: Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum . Gene 1994, 145:69–73.PubMedCrossRef

34. Martinez-Morales F, Borges AC, Martinez A, Shanmugam KT, Ingram LO: Chromosomal integration of heterologous DNA in Escherichia coli with precise removal of markers and replicons used during construction. J Bacteriol 1999, 181:7143–7148.PubMed Competing interests The authors have declared that no competing interests exist. Authors’ contributions MI performed most of experiments Pevonedistat chemical structure and wrote the manuscript. KH designed the study and wrote the manuscript. Both authors have read and approved the final manuscript.”
“Background

Extended-spectrum β-lactamase (ESBL)-producing bacteria represent a major worldwide threat among drug-resistant bacteria in both hospital and community settings [1]. ESBLs are among the Ambler classes A, confer resistance to β-lactam antibiotics except cephamycins and carbapenems, and are inhibited by clavulanic acid [1]. ESBLs are often located on large plasmids that also harbor resistant genes to other antimicrobial classes with resulting multidrug-resistant isolates [2]. The first ESBLs have evolved by genetic mutation very from native β-lactamases TEM and SHV [3][4]. Recently, a novel type of ESBLs, the CTX-M enzymes, emerged worldwide, mostly from Enterobacteriaceae[5, 6]. CTX-M β-lactamases are not closely related to TEM or SHV ESBLs but share high amino-acid identity with chromosomal β-lactamases from Kluyvera spp. [7]. Now, bla CTX-M-15 is recognized as the most widely distributed CTX-M enzyme [8]. It is derived from CTX-M-3 by a substitution of Asp-240-Gly which increases its catalytic efficiency against ceftazidime [9]. bla CTX-M-15 are encoded on plasmids belonging to the incompatibility group IncF [10].

Comments are closed.